Clinical Trials in Massachusetts

Showing 4061-4080 of 15,316 trials

Supporting Treatment Access and Recovery in COD

NCT05138614

This 4-year study will randomize 1,000 people with co-occurring opioid use and mental health disorders (COD) at medication for opioid use disorder (MOUD) clinics to evaluate the effectiveness of MISSION, a multi-component team approach, or its components with MOUD versus MOUD alone, as well as the incremental benefits of MISSION or its components for improving outcomes. We expect that individuals receiving MISSION or its parts + MOUD will show greater improvement over MOUD alone on: engagement, substance use, and mental health.

Opioid Use DisorderMental Health Disorder

University of Massachusetts, Worcester1,000 participantsStarted Mar 2022

Holyoke, Massachusetts, United States • Orange, Massachusetts, United States • Springfield, Massachusetts, United States +2 more locations

COMPLETEDPhase 218 miles

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

NCT02128113

This study assesses the efficacy and safety of two concentrations of omaveloxolone (RTA 408) ophthalmic suspension for the prevention of corneal endothelial cell loss following cataract surgery.

Corneal Endothelial Cell LossOcular PainOcular Inflammation+1 more

Biogen307 participantsStarted May 2014

Laguna Hills, California, United States • Lancaster, California, United States • Cape Coral, Florida, United States +12 more locations

Supporting Treatment Access and Recovery in COD

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

Find Trials by Condition in Massachusetts

Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease

Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial

Aberrant Gene Expression Prostate Carcinoma

Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure

TENS Unit for Analgesia During IUD Insertion

Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD), Withdrawn

A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)

Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy

Deconstructing Post Stroke Hemiparesis

Atlas of Retinal Imaging in Alzheimer's Study

A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches